483 Roundup: Four Drugmakers Cited Over Quality Problems

Four U.S. drug manufacturers were handed Form 483s for quality violations observed at their facilities, such as issues with quality monitoring, facility maintenance and unqualified handling of quality responsibilities.
Source: Drug GMP Report